Long-term CD4+ and CD8+ T-cell responses induced in HIV-uninfected volunteers following intradermal or intramuscular administration of an HIV-lipopeptide vaccine (ANRS VAC16)-Reference-Cited by-同舟云学术

Long-term CD4+ and CD8+ T-cell responses induced in HIV-uninfected volunteers following intradermal or intramuscular administration of an HIV-lipopeptide vaccine (ANRS VAC16)

Published:2013-09 Issue:40 Volume:31 Page:4406-4415
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Launay Odile,Surenaud Mathieu,Desaint Corinne,Ben Hamouda Nadine,Pialoux Gilles,Bonnet Bénédicte,Poizot-Martin Isabelle,Gonzales Gustavo,Cuzin Lise,Bourgault-Villada Isabelle,Lévy Yves,Choppin Jeannine,Durier Christine

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference63 articles.

1. Characterization of a multi-lipopeptides mixture used as an HIV-1 vaccine candidate;Klinguer;Vaccine,1999

2. T-cell responses induced in humans by a human immunodeficiency virus type 1 lipopeptide vaccine;Gahéry-Ségard;J Virol,2000

3. Lipopeptides induce cell-mediated anti-HIV immune responses in seronegative volunteers;Pialoux;AIDS,2001

4. Long-term specific immune responses induced in humans by a human immunodeficiency virus type 1 lipopeptide vaccine: characterization of CD8+-T-cell epitopes recognized;Gahéry-Ségard;J Virol,2003

5. Immunological and virological efficacy of a therapeutic immunization combined with interleukin-2 in chronically HIV-1 infected patients;Lévy;AIDS,2005

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bioconjugated materials in the development of subunit vaccines;Bioconjugated Materials Part 2 Applications in Drug Delivery, Vaccine Formulations and Important Conjugates for Cancer Therapy;2023

2. Palmitoylated antigens for the induction of anti-tumor CD8+ T cells and enhanced tumor recognition;Molecular Therapy - Oncolytics;2021-06

3. Optimal drug control in a four‐dimensional HIV infection model;Optimal Control Applications and Methods;2019-11-27

4. Development of an epitope-based HIV-1 vaccine strategy from HIV-1 lipopeptide to dendritic-based vaccines;Expert Review of Vaccines;2017-09-14

5. Optimal control therapy and vaccination for special HIV-1 model with delay;Theory in Biosciences;2016-08-03